E-LIB Suche - Ergebnisse für: Bidard, Francois-Clement

1

E-Cadherin Mutational Landscape and Outcomes in Breast Inva..:

Djerroudi, Lounes ; Bendali, Amel ; Fuhrmann, Laetitia...
Modern Pathology. 37 (2024) 10 - p. 100570 , 2024

Link: https://doi.org/10.1016/..

2

Tolerance of Concurrent Adjuvant Radiation Therapy and Pemb..:

Tison, Thais ; Loap, Pierre ; Arnaud, Emilie...
Advances in Radiation Oncology. 9 (2024) 3 - p. 101384 , 2024

Link: https://doi.org/10.1016/..

3

Fulvestrant and everolimus efficacy after CDK4/6 inhibitor:..:

Vasseur, Antoine ; Cabel, Luc ; Hego, Caroline...
Oncogene. 43 (2024) 16 - p. 1214-1222 , 2024

Link: https://doi.org/10.1038/..

4

Treatment patterns of patients with HR+/HER2- metastatic br..:

Read, Stephanie H. ; Quignot, Nadia ; Kapso-Kapnang, Raissa...
Breast Cancer Research and Treatment. 204 (2024) 3 - p. 579-588 , 2024

Link: https://doi.org/10.1007/..

5

Sacituzumab govitecan in metastatic triple-negative breast ..:

De Moura, Alexandre ; Loirat, Delphine ; Vaillant, Sarah...
Breast Cancer. 31 (2024) 4 - p. 572-580 , 2024

Link: https://doi.org/10.1007/..

6

Molecular and Clinical Portrait of HER2-low Invasive Lobula..:

Djerroudi, Lounes ; El Sabeh-Ayoun, Ahmad ; Benoist, Camille...
Modern Pathology. 37 (2024) 5 - p. 100463 , 2024

Link: https://doi.org/10.1016/..

7

Elacestrant in ER+, HER2− Metastatic Breast Cancer with ESR..:

Bardia, Aditya ; Cortés, Javier ; Bidard, François-Clément...
Clinical Cancer Research. , 2024

Link: https://doi.org/10.1158/..

8

Could a Long-Acting Prodrug of SN-38 be Efficacious in Saci..:

Santi, Daniel V. ; Ashley, Gary W. ; Cabel, Luc.
BioDrugs. 38 (2024) 2 - p. 171-176 , 2024

Link: https://doi.org/10.1007/..

9

Modeling the novel SERD elacestrant in cultured fulvestrant..:

Dubash, Taronish D. ; Bardia, Aditya ; Chirn, Brian...
Breast Cancer Research and Treatment. 201 (2023) 1 - p. 43-56 , 2023

Link: https://doi.org/10.1007/..

10

Design of SERENA-6, a phase III switching trial of camizest..:

Turner, Nicholas ; Huang-Bartlett, Cynthia ; Kalinsky, Kevin...
Future Oncology. 19 (2023) 8 - p. 559-573 , 2023

Link: https://doi.org/10.2217/..

11

Effective treatment based on monitoring bESR1 mutations – A..:

Bidard, Francois-Clément ; Hardy-Bessard, Anne-Claire ; Delaloge, Suzette
The Lancet Oncology. 24 (2023) 1 - p. e4 , 2023

Link: https://doi.org/10.1016/..

12

Development of sensitive and robust multiplex digital PCR a..:

Corné, Julien ; Quillien, Véronique ; Callens, Céline...
Clinica Chimica Acta. 545 (2023) - p. 117366 , 2023

Link: https://doi.org/10.1016/..

13

PET/CT and SPECT/CT Imaging of HER2-Positive Breast Cancer:

McGale, Jeremy ; Khurana, Sakshi ; Huang, Alice...
Journal of Clinical Medicine. 12 (2023) 15 - p. 4882 , 2023

Link: https://doi.org/10.3390/..

14

Recommandations francophones pour la pratique clinique conc..:

Gligorov, Joseph ; Benderra, Marc-Antoine ; Barthere, Xavier...
Bulletin du Cancer. 110 (2023) 10 - p. 10S1-10S43 , 2023

Link: https://doi.org/10.1016/..

15

Circulating Tumor DNA as a Prognostic Factor in Patients Wi..:

Mariani, Pascale ; Bidard, François-Clément ; Rampanou, Aurore...
Annals of Surgery. 278 (2023) 4 - p. e827-e834 , 2023

Link: https://doi.org/10.1097/..